Sathgen Therapeutics is a clinical-stage biotech company working on bringing the first-in-class and best-in-class drugs ensuring novel treatments for difficult-to-treat cancers and viral infections. Using our expertise in medicinal chemistry, we have developed a pipeline of molecules that are being tested for their anti-cancer properties in breast cancer, prostate cancer, glioblastoma, and others. Our lead molecule has progressed onto phase I clinical trials in patients with advanced solid tumors and in healthy volunteers. Moreover, our lead molecule has also shown efficacy against the SARS-CoV-2 virus, a type of coronavirus, implicating its role in anti-viral therapy as well. We are one of the few discovery-based institutions in India taking drugs ‘from bench-to-bedside’.